BENITEC BIOPHARMA
Company Snapshot
Founded: 1995
Entity Type: Public
Employees: 19
Region: U.S.
Headquarter: California, U.S.
Key Geographics: U.S.
Corporate Address: 3940 Trust Way, Hayward, California 94545 U.S. Tel. +1-510-780-0819 www.benitec.com
Company Overview
Benitec is a biotechnology firm pursuing a unique therapeutic technology platform that combines RNA interference and gene therapy. It is developing a single-shot therapeutic that helps to treat diseases that require multiple doses. It is a development stage company. The technology used by Benitec is DNA-directed RNA interference (ddRNAi). It targets orphan diseases, such as oculopharyngeal muscular dystrophy (OPMD), as well as infectious diseases, such as hepatitis B virus (HBV).
BB-301 for oculopharyngeal muscular dystrophy is currently in the Investigational New Drug (IND) phase.
Benitec has a subsidiary in Australia.
BENITEC BIOPHARMA In News
Company's Business Segments
- Product : RNA Interference Platform, Gene Therapy, Others
- Service : Gene Silencing, Intellectual Property, Partnering
Applications/End User Industries
- Healthcare
- Biotechnology
- Pharmaceuticals
- Regulatory Bodies